Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma. [electronic resource]
Producer: 20040220Description: 775-82 p. digitalISSN:- 0268-3369
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Feasibility Studies
- Female
- Graft Survival
- Humans
- Immunity
- Immunosuppression Therapy
- Lymphoma, B-Cell -- complications
- Lymphoma, Mantle-Cell -- complications
- Male
- Middle Aged
- Peripheral Blood Stem Cell Transplantation -- methods
- Prednisone -- administration & dosage
- Radiotherapy, Adjuvant
- Remission Induction -- methods
- Rituximab
- Survival Analysis
- Transplantation, Autologous
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.